How new tech is changing Alzheimer's treatment
CRISPR could help turn Alzhimer's findings into a cure, but there are several barriers to overcome first
13th August 2018
Web Exclusives
The current landscape for Alzheimer’s drugs
An overview of the latest drug developments in this notoriously-difficult disease area
9th August 2018
Why biosimilars won’t be the only shake up in biologics
The potential for oral delivery could completely change the landscape for biologics
8th August 2018
Digital transformation in life sciences R&D: breaking down barriers
Unclear ambitions and disjointed initiatives are threatening pharmaceutical companies’ ROI from advanced technologies
7th August 2018
Why is there a struggle with linguistic validation?
Ensuring clinical outcome assessment-measures are culturally relevant as well as accurately translated for each target market
3rd August 2018
The Wisdom of Ignorance
Three things consumers can learn from the world of healthcare, and three things healthcare can learn from consumers.
3rd August 2018
Exploring validation and data integrity in pharma
What pharma companies need to know about this important area
3rd August 2018
Patents in the pharma sector – recent developments
What the current patent litigation landscape looks like for pharma now and beyond Brexit
1st August 2018
How to start a clinical research site
Establishing a new research site can be exciting but challenging – to be successful there needs to be a lot of preparation and hard work
31st July 2018
Recruiting for a digital pharma industry
Embracing digital tools to build a digitised workforce
30th July 2018
The digital revolution is coming, but not how you think
The NHS recently turned 70 - but in a modern digital sense the health service is only 40
27th July 2018
Company focus: Liva Healthcare
Digital health coach platform Liva Healthcare partnered with the NHS late last year to help the health service in diabetes prevention. We spoke to the company about how health apps can make a difference in healthcare
26th July 2018
A digital goldrush could harm healthcare
Digital change is coming – but pharma must be wary of an Uber-style goldrush, which could put patients in danger
26th July 2018
How pharma can use trust patterns in advocacy
The pharmaceutical industry has a legitimate interest in having a share of voice on public policy issues and engaging with its constituents about the value of treatments it provides.
23rd July 2018
When health apps meet VR
How AR, VR and gamification technology is being integrated with AI apps to enhance health outcomes
18th July 2018
